Combining Experience and Expertise
By bringing together OSI’s long-standing experience in drug discovery and chemistry with BMC’s excellence in biomedicine, biotechnology, and molecular life sciences, NIRI is creating a new standard of quality in research. By 2026, the institute is strategically developing the strongest platform in the Baltics for drug discovery, medical technology, and diagnostic method development, built on international collaboration, knowledge transfer, and solutions that address societal needs.
